Benitec Biopharma Inc.

NASDAQ: BNTC · Real-Time Price · USD
12.93
0.27 (2.13%)
At close: Aug 15, 2025, 3:59 PM
11.05
-14.54%
After-hours: Aug 15, 2025, 07:55 PM EDT

Benitec Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Cash & Equivalents
103.58M 78.28M 67.84M 50.87M 14.16M 20.37M 25.86M 2.48M 6.55M 10.54M 16.53M 4.06M 8.63M 12.33M 15.73M 19.77M 11.99M 14.01M 7.45M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
90K 67K 81K 87K 94K 76K 110K 122K 130K 141K 144K 160K 181K 186K 194K 194K 206K 219K 9K
Receivables
3K 2K 4K 229K 53K 53K 53K 55K 56K 68K 3K 3K 5K 5K 3K 25K 10K 21K 18K
Inventory
n/a n/a n/a 63K 1.20 14K 13K 13K n/a -0.2 0.50 1.80 n/a n/a n/a n/a n/a n/a 587K
Other Current Assets
424K 428K 490K 516K 157K 355K 482K 1.18M 788K 14K 13K 14K n/a n/a n/a 15K 409K 352K 1K
Total Current Assets
104.01M 78.71M 68.33M 51.67M 14.37M 20.8M 26.41M 3.73M 7.39M 10.97M 17.08M 4.82M 8.84M 12.67M 16.37M 20.61M 12.41M 14.38M 8.06M
Property-Plant & Equipment
1.11M 288K 358K 449K 539K 451K 531K 613K 695K 789K 890K 993K 1.04M 1.16M 1.27M 577K 815K 910K 851K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
1.2M 355K 439K 536K 633K 527K 641K 735K 825K 930K 1.03M 1.15M 1.22M 1.34M 1.46M 771K 1.02M 1.13M 860K
Total Assets
105.21M 79.07M 68.77M 52.21M 15M 21.35M 27.05M 4.46M 8.22M 11.9M 18.11M 5.97M 10.06M 14.01M 17.84M 21.38M 13.43M 15.51M 8.92M
Account Payables
433K 593K 903K 1.35M 815K 2.62M 1.53M 1.14M 635K 531K 608K 422K 100K 682K 323K 274K 1.64M 87K 299K
Deferred Revenue
n/a n/a n/a n/a -292K -2.62M -1.53M n/a n/a n/a n/a -1.2M n/a -1.26M n/a n/a n/a n/a n/a
Short-Term Debt
n/a 137K n/a 284K 292K 286K 280K 275K n/a 263K 258K 252K 232K 213K 194K 213K 208K 203K 198K
Other Current Liabilities
426K 1.82M 2.94M 2.81M 1.44M 1.96M 1.95M 1.75M 429K 995K 1.37M 1.14M 932K 939K 477K 393K 204K 18K 127K
Total Current Liabilities
7.03M 3.09M 4.55M 4.92M 3.44M 5.75M 4.53M 3.98M 3.15M 2.49M 3.01M 2.53M 1.91M 2.48M 1.6M 1.37M 2.44M 779K 1.02M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 38K 41K 38K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
613K 38K 41K 38K 62K 137K 211K 284K 354K 422K 491K 559K 635K 698K 760K n/a 54K 108K 161K
Total Liabilities
7.64M 3.13M 4.59M 4.96M 3.5M 5.88M 4.75M 4.26M 3.51M 2.91M 3.5M 3.09M 2.54M 3.18M 2.36M 1.37M 2.5M 887K 1.18M
Total Debt
959K 137K 211K 284K 354K 423K 491K 559K 623K 685K 749K 811K 867K 911K 954K 213K 262K 311K 359K
Common Stock
2K 2K 1K 1K n/a n/a n/a n/a 3K 3K 3K 1K 1K 1K 1K 1K 5K 4K 1K
Retained Earnings
-212.03M -202.68M -195.32M -190.26M -184.92M -180.64M -173.84M -167.89M -163.23M -158.83M -153.42M -148.33M -143.26M -139.99M -135.16M -130.12M -126.12M -122.21M -119.34M
Comprehensive Income
-716K -688K -993K -892K -835K -952K -780K -830K -853K -898K -738K -1.25M -1.51M -1.27M -1.22M -1.46M -1.59M -1.57M -1.77M
Shareholders Equity
97.57M 75.94M 64.18M 47.25M 11.5M 15.47M 22.31M 202K 4.71M 8.99M 14.61M 2.88M 7.52M 10.84M 15.47M 20.01M 10.93M 14.63M 7.74M
Total Investments
n/a n/a n/a 63K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a